Arvinas (ARVN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Arvinas, Inc. (ARVN) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Arvinas Inc (NASDAQ:ARVN) was the target of a large increase in short interest in April. As of April 15th, there was short interest totalling 2,900,000 shares, an increase of 8.2% from the March 31st
Shares of Arvinas Inc (NASDAQ:ARVN) have been assigned a consensus rating of “Buy” from the thirteen brokerages that are currently covering the company, MarketBeat reports. Two analysts have rated
Arvinas Inc (NASDAQ:ARVN) – Analysts at Wedbush raised their Q2 2020 earnings per share estimates for Arvinas in a research report issued on Tuesday, April 28th. Wedbush analyst R. Driscoll now expe
As you might know, Arvinas, Inc. (NASDAQ:ARVN) just kicked off its latest first-quarter results with some very strong...
Arvinas, Inc. (NASDAQ:ARVN) defied analyst predictions to release its quarterly results, which were ahead of market...
5AM Venture Management LLC lessened its holdings in Arvinas Inc (NASDAQ:ARVN) by 27.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Excha
Shares of Arvinas Inc (NASDAQ:ARVN) hit a new 52-week high during mid-day trading on Wednesday following a better than expected earnings announcement. The company traded as high as $58.00 and last tra
Arvinas Inc (NASDAQ:ARVN) – Investment analysts at Piper Sandler reduced their Q2 2020 EPS estimates for shares of Arvinas in a research report issued to clients and investors on Tuesday, April 28th
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29)• Arvinas Inc (NASDAQ: ARVN) • Biondvax Pharmaceu
Arvinas Inc (NASDAQ:ARVN) was the recipient of unusually large options trading on Wednesday. Stock investors bought 2,102 call options on the stock. This is an increase of 2,316% compared to the typic
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) • Arvinas Inc (NASDAQ...
Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Hormel Foods, Tyson Foods and Zebra Technologies, on Wednesday. HIGHLIGHTS
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on Arvinas Holding Company (ARVN) today and set a price target of $60.00. The company's shares
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE